Ceralifimod, 891859-12-4 also known as ONO-4641, is a next-generation sphingosine 1-phosphate (S1P) receptor agonist selective for S1P receptors 1 and 5. In vitro, ONO-4641 showed highly potent agonistic activities versus S1P receptors 1 and 5 [half maximal effective concentration (EC(50) ) values of 0·0273 and 0·334 nM, respectively]. ONO-4641 decreased peripheral blood lymphocyte counts in rats by inhibiting lymphocyte egress from secondary lymphoid tissues. ONO-4641 prevented relapse of disease in a non-obese diabetic mouse model of relapsing-remitting EAE. ONO-4641 may provide therapeutic benefits in the treatment of multiple sclerosis.
Name: Ceralifimod
CAS#: 891859-12-4
Chemical Formula: C27H33NO4
Exact Mass: 435.24096
Molecular Weight: 435.56
Elemental Analysis: C, 74.45; H, 7.64; N, 3.22; O, 14.69
CAS#: 891859-12-4
Chemical Formula: C27H33NO4
Exact Mass: 435.24096
Molecular Weight: 435.56
Elemental Analysis: C, 74.45; H, 7.64; N, 3.22; O, 14.69
Synonym: ONO-4641; ONO 4641; ONO4641; Ceralifimod
IUPAC/Chemical Name: 1-((6-((2-methoxy-4-propylbenzyl)oxy)-1-methyl-3,4-dihydronaphthalen-2-yl)methyl)azetidine-3-carboxylic acid
InChi Key: QDDQIPUKAXBMBX-UHFFFAOYSA-N
InChi Code: InChI=1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30)
SMILES Code: CCCC1=CC=C(COC2=CC(CCC(CN3CC(C(O)=O)C3)=C4C)=C4C=C2)C(OC)=C1
